The estimated Net Worth of Michael O'keefe Sullivan is at least $314 Tisíc dollars as of 29 March 2022. Mr Sullivan owns over 20,000 units of Oragenics Inc stock worth over $17,128 and over the last 12 years he sold OGEN stock worth over $0. In addition, he makes $297,210 as CFO, Sec. a Treasurer & Interim Principal Exec. Officer at Oragenics Inc.
Mr has made over 1 trades of the Oragenics Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of OGEN stock worth $7,000 on 29 March 2022.
The largest trade he's ever made was buying 20,000 units of Oragenics Inc stock on 29 March 2022 worth over $7,000. On average, Mr trades about 1,429 units every 0 days since 2012. As of 29 March 2022 he still owns at least 34,255 units of Oragenics Inc stock.
You can see the complete history of Mr Sullivan stock trades at the bottom of the page.
Michael O. Sullivan CPA is the CFO, Sec., Treasurer & Interim Principal Exec. Officer at Oragenics Inc.
As the CFO, Sec. a Treasurer & Interim Principal Exec. Officer of Oragenics Inc, the total compensation of Mr CPA at Oragenics Inc is $297,210. There are no executives at Oragenics Inc getting paid more.
Mr CPA is 65, he's been the CFO, Sec. a Treasurer & Interim Principal Exec. Officer of Oragenics Inc since . There are 2 older and 5 younger executives at Oragenics Inc. The oldest executive at Oragenics Inc is Dr. Frederick W. Telling Ph.D., 69, who is the Exec. Chairman.
Michael's mailing address filed with the SEC is 4902 EISENHOWER BOULEVARD, , TAMPA, FL, 33634.
Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez a Robert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.
oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.
Oragenics Inc executives and other stock owners filed with the SEC include: